1339. Effects of Tixagevimab-Cilgavimab in Clinical Practice is Consistent with Preliminary Neutralization Studies

BACKGROUND: Emergency use of tixagevimab-cilgavimab was based on data collected prior to the emergence of SARS-CoV-2 omicron variant and subvariants. Dosing recommendations changed twice based on neutralization data alone, leading to patients receiving different doses at varying intervals. We provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Dluzynski, Daniela, Ssentongo, Paddy, Shaheen, Shareef, Maglakelidze, Natella, Hale, Cory, Henao, Maria Paula, Chinchilli, Vernon M, Paules, Catharine I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678513/
http://dx.doi.org/10.1093/ofid/ofad500.1176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678513/
http://dx.doi.org/10.1093/ofid/ofad500.1176

Ejemplares similares